Heparin and Lovenox: What the Oral and Maxillofacial Surgeon Needs to Know.
For the oral and maxillofacial surgeon, many patients will be on heparin products during surgery. So far, there is no standardized approach to treating anticoagulated patients during oral and maxillofacial surgical procedures. When a patient is on heparin therapy, heparin may be stopped 4 to 6 hours before surgery and resumed once hemostasis is achieved, usually within 24 hours. If low-molecular-weight heparin is administered, the treatment is generally stopped at least 12 hours before surgery and then resumed in a similar fashion. Local measures are generally enough to provide adequate hemostasis.
Division of Oral and Maxillofacial Surgery, Department of Craniofacial Sciences, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, USA.
LisaMarie Di
LD
Pasquale
Private Practice, Greater Waterbury OMS, 435 Highland Avenue, Suite 100, Cheshire, CT 06410, USA; Beau Visage Med Spa, 435 Highland Avenue, Suite 100, Cheshire, CT 06410, USA. Electronic address: eferneini@yahoo.com.
Elie M
EM
Ferneini
D000925:Anticoagulants / Q000008:administration & dosage* / Q000627:therapeutic use; D017984:Enoxaparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006488:Hemostasis, Surgical / Q000379:methods*; D006493:Heparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D054539:Medication Therapy Management; D019647:Oral Surgical Procedures
D000925:Anticoagulants; D017984:Enoxaparin; D006493:Heparin
Anticoagulation; Fondaparinux; Heparin; Lovenox; Protamine sulfate